WPD Pharmaceuticals Inc
WPD Pharmaceuticals Inc. does not have any significant operations. Previously, it was engaged in the research and development of medicinal products in the fields of oncology. The company is headquartered in Vancouver, Canada.
Market Cap & Net Worth: WPD Pharmaceuticals Inc (WPDPF)
WPD Pharmaceuticals Inc (PINK:WPDPF) has a market capitalization of $115.99K ($115.99K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #41554 globally and #13510 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying WPD Pharmaceuticals Inc's stock price $0.00 by its total outstanding shares 115987000 (115.99 Million).
WPD Pharmaceuticals Inc Market Cap History: 2020 to 2024
WPD Pharmaceuticals Inc's market capitalization history from 2020 to 2024. Data shows change from $25.52 Million to $115.99K (-72.18% CAGR).
WPD Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how WPD Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of WPDPF by Market Capitalization
Companies near WPD Pharmaceuticals Inc in the global market cap rankings as of March 19, 2026.
Key companies related to WPD Pharmaceuticals Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
WPD Pharmaceuticals Inc Historical Marketcap From 2020 to 2024
Between 2020 and today, WPD Pharmaceuticals Inc's market cap moved from $25.52 Million to $ 115.99K, with a yearly change of -72.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $115.99K | +400.00% |
| 2023 | $23.20K | 0.00% |
| 2022 | $23.20K | -99.37% |
| 2021 | $3.68 Million | -85.59% |
| 2020 | $25.52 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 28th, 2025 the market cap of WPD Pharmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $115.99K USD |
| MoneyControl | $115.99K USD |
| MarketWatch | $115.99K USD |
| marketcap.company | $115.99K USD |
| Reuters | $115.99K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.